Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-04-04 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document details specific transactions made by Novozymes under its stock buyback program, including the number of shares purchased, average prices, and total transaction values. It also mentions the total number of treasury shares held by the company. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2016-04-04 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement detailing specific transactions related to Novozymes' share buyback program (aktietilbagekøbsprogram). It provides a table of daily share repurchases, total transaction values, and the impact on the company's treasury shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2016-04-04 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-04-01 Danish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 98% confidence The document explicitly states it is a "Major shareholder announcement" and details a change in the holding percentage of a major shareholder (Baillie Gifford & Co) from 4.99% to 5.04%, referencing the Danish Securities Trading Act. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2016-04-01 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 92% confidence The document is an announcement under section 29 of the Danish Securities Trading Act indicating that Baillie Gifford & Co has crossed the 5% threshold of Novozymes’ share capital. This is a notification of a change in significant share ownership levels, fitting the definition of Major Shareholding Notification.
2016-04-01 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is a 'Storaktionærmeddelelse' (Major Shareholder Announcement) from Novozymes. It explicitly states that Baillie Gifford & Co has increased its ownership of B shares from 4.99% to 5.04%, crossing a regulatory threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2016-04-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.